Page last updated: 2024-11-05

urapidil and Coronary Stenosis

urapidil has been researched along with Coronary Stenosis in 2 studies

Coronary Stenosis: Narrowing or constriction of a coronary artery.

Research Excerpts

ExcerptRelevanceReference
"Fractional flow reserve (FFR, calculated by coronary pressure measurements during adenosine-induced hyperaemia) was assessed in 85 patients with an intermediate coronary stenosis (mean diameter stenosis of 50+/-1%) and normal left ventricular function which were divided into the following three groups: (a) 33 patients before and after IC bolus of phentolamine, an alpha1-, alpha2-adrenergic blocker; (b) 32 patients before and after IC bolus of urapidil, a selective alpha1-adrenergic blocker; (c) 20 patients before and after IC bolus of saline."3.72Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. ( Aarnoudse, W; Barbato, E; Bartunek, J; De Bruyne, B; Heyndrickx, GR; Pijls, NH; Staelens, F; Vanderheyden, M; Wijns, W, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolyva, C1
Verhoeff, BJ1
Spaan, JA1
Piek, JJ1
Siebes, M1
Barbato, E1
Bartunek, J1
Aarnoudse, W1
Vanderheyden, M1
Staelens, F1
Wijns, W1
Heyndrickx, GR1
Pijls, NH1
De Bruyne, B1

Trials

1 trial available for urapidil and Coronary Stenosis

ArticleYear
Increased diastolic time fraction as beneficial adjunct of alpha1-adrenergic receptor blockade after percutaneous coronary intervention.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Angioplasty, Balloon, C

2008

Other Studies

1 other study available for urapidil and Coronary Stenosis

ArticleYear
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
    European heart journal, 2004, Volume: 25, Issue:22

    Topics: Adrenergic alpha-Antagonists; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Coronar

2004